HomeCompareKHRWF vs DGRO

KHRWF vs DGRO: Dividend Comparison 2026

KHRWF yields 13333.33% · DGRO yields 2.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KHRWF wins by $944051876715324800.00M in total portfolio value
10 years
KHRWF
KHRWF
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full KHRWF calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.10%
Share price
$70.18
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$235.38
Full DGRO calculator →

Portfolio growth — KHRWF vs DGRO

📍 KHRWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKHRWFDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KHRWF + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KHRWF pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KHRWF
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$178.14/yr
After 10yr DRIP, annual income (after tax)
$200.07/yr
At 15% tax rate, KHRWF beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KHRWF + DGRO for your $10,000?

KHRWF: 50%DGRO: 50%
100% DGRO50/50100% KHRWF
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KHRWF buys
0
DGRO buys
0
No recent congressional trades found for KHRWF or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKHRWFDGRO
Forward yield13333.33%2.10%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$944051876715324800.00M$31.6K
Annual income after 10y$930,326,183,604,330,300,000,000.00$235.38
Total dividends collected$943142383073684224.00M$2.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: KHRWF vs DGRO ($10,000, DRIP)

YearKHRWF PortfolioKHRWF Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$1,344,033$1,333,333.33$11,290$209.57+$1.33MKHRWF
2$168,918,905$167,480,789.20$12,722$213.54+$168.91MKHRWF
3$19,852,785,021$19,672,041,793.12$14,314$217.18+$19852.77MKHRWF
4$2,182,013,981,744$2,160,771,501,770.83$16,080$220.53+$2182013.97MKHRWF
5$224,287,824,199,531$221,953,069,239,064.90$18,040$223.59+$224287824.18MKHRWF
6$21,561,870,489,323,890$21,321,882,517,430,390.00$20,215$226.40+$21561870489.30MKHRWF
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$22,627$228.96+$1938749165623.51MKHRWF
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$25,302$231.31+$163055200603353.69MKHRWF
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$28,268$233.44+$12827750571022998.00MKHRWF
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$31,557$235.38+$944051876715324800.00MKHRWF

KHRWF vs DGRO: Complete Analysis 2026

KHRWFStock

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Full KHRWF Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this KHRWF vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KHRWF vs SCHDKHRWF vs JEPIKHRWF vs OKHRWF vs KOKHRWF vs MAINKHRWF vs VIGKHRWF vs NOBLKHRWF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.